Clinical Trials Directory

Trials / Completed

CompletedNCT02322294

Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight

A Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Effects of 8 Weeks Use of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight as Compared to Placebo

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
50 (actual)
Sponsor
KGK Science Inc. · Industry
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is investigating the effects of 8 weeks of supplementation with Glucodia™, on glucose parameters, triglycerides and body weight as compared to a placebo. Half of the subjects will be administered Glucodia™, while the other half will receive placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlucodia™
OTHERPlacebo

Timeline

Start date
2015-01-01
Primary completion
2016-03-01
First posted
2014-12-23
Last updated
2016-06-09

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02322294. Inclusion in this directory is not an endorsement.

Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight (NCT02322294) · Clinical Trials Directory